Karl Handelsman

Investor · Codon Capital · San Francisco, United States

Email

Verified, deliverable email

Founder & Investor at Codon Capital

Stages: Series A, Seed
Cheque size: €92k–€4.6M
Location: San Francisco, United States
Freshness: Verified today

Notable investments

Bonum TherapeuticsSeries A · $93M · 2022
Good TherapeuticsSeries A · $11M · 2019
Clear LabsSeries B · $21M · 2018

Frequently co-invests with

John McKearnRiverVest2×Monique SchiersingRoche Venture Fund2×Samuel BjorkDigitalis Ventures2×Aydin SenkutFelicis VenturesChris SklarinAlumni VenturesGreg YapMenlo VenturesKrishna Yeshwant (GV (Google Ventures))Kyle KurpinskiTencent HoldingsMiguel VallsAlta Life Sciences

Background

MemberLife Science Angels2014–present
Catalyst Advisory PanelUCSF2013–present
SPARK Selection CommitteeStanford University2013–present
Founder & InvestorCodon Capital2013–present
Senior Advisor, Roche Venture FundGenentech2016–2021
MentorCalifornia Inst. for Regenerative Medicine2013–2016
Lean Launchpad for Therapeutics/Tools InstructorUCSF2013–2016
General Partner EmeritusCMEA Capital2013–2014
Managing Director/General PartnerCMEA Capital1999–2013
Director, Business DevelopmentMillennium Pharmaceuticals1996–1997
Manager, Business DevelopmentTularik1992–1996

Similar investors

Q MotiwalaManaging Director, DNX Ventures

Blake PateAnalyst, Bios Partners

Bob MaInvestor, Wind Ventures

Pierpaolo BarbieriAngel, Independent

Phyllis WhiteleyVenture Partner, Wildcat Venture Partners

Rachel GellerManaging Director, Insight Partners

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Karl Handelsman? Request removal of this listing.